New developments in dementia

Valery Feigin MD, PhD

Associate Professor, Clinical Trials Research Unit Faculty of Health and Medical Sciences, University of Auckland Private Bag 92019, Auckland, New Zealand Tel.: 64 9 3737599 Fax: 64 9 3731710

Search for more papers by this author

Valery Feigin MD, PhD,

Valery Feigin MD, PhD

Associate Professor, Clinical Trials Research Unit Faculty of Health and Medical Sciences, University of Auckland Private Bag 92019, Auckland, New Zealand Tel.: 64 9 3737599 Fax: 64 9 3731710

Search for more papers by this author

First published: 04 March 2003

https://doi.org/10.1034/j.1600-0404.2000.02172.x

Citations: 1

No abstract is available for this article.

References

1 Lobo A, Launer LJ, Fratiglioni L et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S4–S9.
CAS PubMed Web of Science® Google Scholar
2 Witthaus E, Ott A, Barendregt JJ, Breteler M, Bonneux L. Burden of mortality and morbidity from dementia. Alzheimer Dis Associated Disorders 1999; 13: 176–81.
10.1097/00002093-199907000-00011
CAS PubMed Web of Science® Google Scholar
3 Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 1994; 5: 189–92.
10.1159/000106721
CAS PubMed Web of Science® Google Scholar
4 Coria F, Rubio I, Bayon C. Alzheimer's disease, beta-amyloidosis, and aging. Rev Neurosci 1994; 5: 275–92.
10.1515/REVNEURO.1994.5.4.275
PubMed Web of Science® Google Scholar
5 Hofman A, Ott A, Breteler MMB et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151–4.
10.1016/S0140-6736(96)09328-2
CAS PubMed Web of Science® Google Scholar
6 Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimer disease. Alzheimer Dis Associated Disorders 1999; 13 ( Suppl. 3 ): S106–S114.
10.1097/00002093-199912003-00016
PubMed Web of Science® Google Scholar
7 Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease: The Nun Study. JAMA 1997; 277: 813–7.
10.1001/jama.1997.03540340047031
CAS PubMed Web of Science® Google Scholar
8 Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [see comments]. Lancet 1997; 349: 151–4.
10.1016/S0140-6736(96)09328-2
CAS PubMed Web of Science® Google Scholar
9 De La Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33: 1152–62.
10.1161/01.STR.0000014421.15948.67
CAS PubMed Web of Science® Google Scholar
10 Slooter AJ, Tang MX, Van Duijn CM et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997; 277: 818–21.
CAS PubMed Web of Science® Google Scholar
11 Breteler MM, Van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44: 1246–52.
10.1212/WNL.44.7.1246
CAS PubMed Web of Science® Google Scholar
12 Schmidt R, Schmidt H, Fazekas F. Vascular risk factors in dementia. J Neurol 2000; 247: 81–7.
10.1007/s004150050021
CAS PubMed Web of Science® Google Scholar
13 Akiyama H, Barger S, Barnum S et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383–421.
10.1016/S0197-4580(00)00124-X
CAS PubMed Web of Science® Google Scholar

New developments in dementia

References

Citing Literature